Paper34825976
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study.
Moreno G and 30 others. Ann Intensive Care, 2021. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study. Papers, record 34825976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34825976
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RBCF2020 | ricardo barri casanovas foundation | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32880390 | Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China. | J Clin Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32880390 | PubMed |
| 2 | 34011029 | Corticosteroid therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials. | Medicine (Baltimore) | 2021 | https://conductscience.org/library/papers/34011029 | PubMed |
| 3 | 34229747 | Risk factors and outcomes of ventilator-associated pneumonia in COVID-19 patients: a propensity score matched analysis. | Crit Care | 2021 | https://conductscience.org/library/papers/34229747 | PubMed |
| 4 | 33933206 | Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. | Lancet | 2021 | https://conductscience.org/library/papers/33933206 | PubMed |
| 5 | 33588914 | Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain. | Crit Care | 2021 | https://conductscience.org/library/papers/33588914 | PubMed |
| 6 | 33571009 | Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis. | Clin Appl Thromb Hemost | 2021 | https://conductscience.org/library/papers/33571009 | PubMed |
| 7 | 32498689 | Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature. | Crit Care | 2020 | https://conductscience.org/library/papers/32498689 | PubMed |
| 8 | 32876694 | Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. | JAMA | 2020 | https://conductscience.org/library/papers/32876694 | PubMed |
| 9 | 33876268 | Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/33876268 | PubMed |
| 10 | 33211135 | Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/33211135 | PubMed |
| 11 | 27133972 | Acute respiratory distress syndrome. | Lancet | 2016 | https://conductscience.org/library/papers/27133972 | PubMed |
| 12 | 33172477 | Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis. | Crit Care | 2020 | https://conductscience.org/library/papers/33172477 | PubMed |
| 13 | 32556826 | Ethical dilemmas due to the Covid-19 pandemic. | Ann Intensive Care | 2020 | https://conductscience.org/library/papers/32556826 | PubMed |
| 14 | 34347836 | Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network. | PLoS One | 2021 | https://conductscience.org/library/papers/34347836 | PubMed |
| 15 | 32785710 | Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32785710 | PubMed |
| 16 | 33298370 | Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials. | J Cardiothorac Vasc Anesth | 2021 | https://conductscience.org/library/papers/33298370 | PubMed |
| 17 | 33317589 | Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. | Crit Care | 2020 | https://conductscience.org/library/papers/33317589 | PubMed |
| 18 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 19 | 16356211 | Evaluating mortality in intensive care units: contribution of competing risks analyses. | Crit Care | 2006 | https://conductscience.org/library/papers/16356211 | PubMed |
| 20 | 33316235 | Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype. | Chest | 2021 | https://conductscience.org/library/papers/33316235 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42343472 | Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice. | Pneumonia (Nathan) | 2026 | https://conductscience.org/library/papers/42343472 | PubMed |
| 41882647 | Time-varying associations between corticosteroid dose and hospital mortality in ARDS: a sliding-window analysis of MIMIC-IV. | BMC Pulm Med | 2026 | https://conductscience.org/library/papers/41882647 | PubMed |
| 40055260 | End-of-life decision disparities according to the gross national income in critically ill patients: a secondary analysis of the ETHICUS-2 study. | Ann Intensive Care | 2025 | https://conductscience.org/library/papers/40055260 | PubMed |
| 39414922 | Corticosteroids for hospitalized patients with severe/critical COVID-19: a retrospective study in Chongqing, China. | Sci Rep | 2024 | https://conductscience.org/library/papers/39414922 | PubMed |
| 39310055 | Glucocorticoid therapy for acute respiratory distress syndrome: Current concepts. | J Intensive Med | 2024 | https://conductscience.org/library/papers/39310055 | PubMed |
| 38802435 | In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study. | Sci Rep | 2024 | https://conductscience.org/library/papers/38802435 | PubMed |
| 38436606 | Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023. | Rev Esp Quimioter | 2024 | https://conductscience.org/library/papers/38436606 | PubMed |
| 38028685 | Prescription patterns in an intensive care unit of COVID-19 patients in Bangladesh: A cross-sectional study. | Health Sci Rep | 2023 | https://conductscience.org/library/papers/38028685 | PubMed |
| 37460259 | Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection. | BMJ Open | 2023 | https://conductscience.org/library/papers/37460259 | PubMed |
| 37221085 | Factors Associated With Prolonged Ventilation in Patients Receiving Prone Positioning Protocol With Muscle Relaxants for Severe COVID-19 Pneumonia. | Respir Care | 2023 | https://conductscience.org/library/papers/37221085 | PubMed |
| 37038264 | Corticosteroid outcome may be dependent of duration of use in severe COVID-19. | Korean J Intern Med | 2023 | https://conductscience.org/library/papers/37038264 | PubMed |
| 36983480 | Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients. | J Fungi (Basel) | 2023 | https://conductscience.org/library/papers/36983480 | PubMed |
| 36818803 | Safety and efficacy of methylprednisolone versus dexamethasone in critically ill patients with COVID-19 acute respiratory distress syndrome: a retrospective study. | Ther Adv Infect Dis | 2023 | https://conductscience.org/library/papers/36818803 | PubMed |
| 36814234 | Comparison of systemic inflammatory profiles in COVID-19 and community-acquired pneumonia patients: a prospective cohort study. | Respir Res | 2023 | https://conductscience.org/library/papers/36814234 | PubMed |
| 36680091 | Kinetics of Immune Subsets in COVID-19 Patients Treated with Corticosteroids. | Viruses | 2022 | https://conductscience.org/library/papers/36680091 | PubMed |
| 36576189 | Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study. | BMJ Open | 2022 | https://conductscience.org/library/papers/36576189 | PubMed |
| 36213939 | Assessment of Admission COVID-19 Associated Hyperinflammation Syndrome Score in Critically-Ill COVID-19 Patients. | J Intensive Care Med | 2023 | https://conductscience.org/library/papers/36213939 | PubMed |
| 35971278 | Effect of corticosteroid therapy on mortality in COVID-19 patients-A systematic review and meta-analysis. | Rev Med Virol | 2022 | https://conductscience.org/library/papers/35971278 | PubMed |
| 35918776 | Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS. | Crit Care | 2022 | https://conductscience.org/library/papers/35918776 | PubMed |
| 35727348 | Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study. | Intensive Care Med | 2022 | https://conductscience.org/library/papers/35727348 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 | NCBI Gene |
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
| CLEC4D | 338339 | PubTator's text mining | https://conductscience.org/library/genes/338339 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| ITLN1 | 55600 | PubTator's text mining | https://conductscience.org/library/genes/55600 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34825976
GET https://conductscience.org/api/papers/v1/34825976/authors?page=2